Tafamidis
Common brands: Vyndamax, Lasix, Furosemide, Lasix Onyu, Aldactone
Top reporter: Pfizer Laboratories Div Pfizer Inc
Loop Diuretic [EPC]Aldosterone Antagonist [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]Factor Xa Inhibitor [EPC]HMG-CoA Reductase Inhibitor [EPC]
11,192
Total Reports
10,417
Serious Reports
3,835
Death Reports
30
Reported Reactions
Death Report Ratio: High (34.27%)
Patient Demographics
Reported Adverse Reactions (30)
Side effects reported in FDA adverse event reports for Tafamidis.
| # | Reaction | Reports | % of Total |
|---|---|---|---|
| 1 | DEATH | 2,937 | |
| 2 | DYSPNOEA | 742 | |
| 3 | OFF LABEL USE | 652 | |
| 4 | CARDIAC FAILURE | 566 | |
| 5 | FATIGUE | 547 | |
| 6 | FALL | 443 | |
| 7 | ATRIAL FIBRILLATION | 368 | |
| 8 | DIZZINESS | 343 | |
| 9 | MALAISE | 335 | |
| 10 | ASTHENIA | 315 | |
| 11 | HYPOACUSIS | 303 | |
| 12 | CARDIAC FAILURE CONGESTIVE | 295 | |
| 13 | WEIGHT DECREASED | 289 | |
| 14 | CARDIAC DISORDER | 274 | |
| 15 | CONDITION AGGRAVATED | 274 | |
| 16 | CEREBROVASCULAR ACCIDENT | 249 | |
| 17 | PRODUCT DOSE OMISSION ISSUE | 239 | |
| 18 | PERIPHERAL SWELLING | 236 | |
| 19 | COVID-19 | 231 | |
| 20 | FLUID RETENTION | 230 | |
| 21 | ILLNESS | 218 | |
| 22 | PNEUMONIA | 218 | |
| 23 | DIARRHOEA | 213 | |
| 24 | CARDIAC AMYLOIDOSIS | 212 | |
| 25 | DISEASE PROGRESSION | 209 | |
| 26 | DRUG INEFFECTIVE | 209 | |
| 27 | GAIT DISTURBANCE | 204 | |
| 28 | DYSPHAGIA | 182 | |
| 29 | PAIN | 149 | |
| 30 | URINARY TRACT INFECTION | 148 |
Important Disclaimer
FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.